Edges in Network
| Network | GSE5851_top500tf - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | C11orf9 |
| Upstream (Parents) |
|---|
| (<<) GLI2 → C11orf9 |
| (<<) DMRT1 → C11orf9 |
| (<<) TFAP2B → C11orf9 |
| (<<) NPAT → C11orf9 |
| (<<) HNF1B → C11orf9 |
| (<<) SIX1 → C11orf9 |
| (<<) TCF4 → C11orf9 |
| (<<) FOSB → C11orf9 |
| (<<) NKX3-1 → C11orf9 |
| (<<) FOXF1 → C11orf9 |
| Downstream (Children) |
|---|
| C11orf9 → WT1 (>>) |
| C11orf9 → FOXE1 (>>) |
| C11orf9 → NR2E1 (>>) |
| C11orf9 → BRD8 (>>) |
| C11orf9 → GCM1 (>>) |
| C11orf9 → TADA3 (>>) |
| C11orf9 → ZNF446 (>>) |
| C11orf9 → SMAD9 (>>) |
| C11orf9 → HOXC10 (>>) |
| C11orf9 → GATA1 (>>) |
| C11orf9 → SCRT1 (>>) |
